STVN Stock Analysis: Buy, Sell, or Hold?
STVN - Stevanato Group S.p.A.
$13.73
-0.02 (-0.15%)
▼
5d:
+0.81%
30d:
-21.54%
90d:
-31.76%
HOLD
MODERATE Confidence
Analysis Updated: Apr 2, 2026 12:00 AM ET
Earnings: May 14, 2026
Get Alerted When STVN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: STVN shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: STVN shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$36.16
Based on 12.7% avg growth
INTRINSIC VALUE TODAY
$22.45
38.8% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 23.5x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: STVN is currently trading at $13.73, which is considered oversold relative to its 30-day fair value range of $14.11 to $15.82. From a valuation perspective, the stock is trading at a discount (Forward PE: 16.1) compared to its historical average (23.5). Remarkably, the market is currently pricing in an annual earnings decline of 11.9% over the next few years. This pessimistic expectation contrasts with the company's recent 0.3% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, STVN is in a strong downtrend. Immediate support is located at $12.89, while resistance sits at $15.55.
Market Sentiment: STVN has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $25.17 (+83.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, STVN is in a strong downtrend. Immediate support is located at $12.89, while resistance sits at $15.55.
Market Sentiment: STVN has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $25.17 (+83.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$14.11 -
$15.82
Company Quality Score
50/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.1%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 83.3% below Wall St target ($25.17)
Fair Price Analysis
30-Day Fair Range
$14.11 -
$15.82
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$12.89
Resistance Level
$15.55
Current Trend
Strong Downtrend
Technical data as of
Apr 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
16.07
Wall Street Target
$25.17
(+83.3%)
Revenue Growth (YoY)
4.8%
Earnings Growth (YoY)
0.3%
Profit Margin
11.8%
Valuation Discount vs History
-11.9% cheaper
PE vs Historical
16.1 vs 23.5
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-11.9%
(market-implied from PE analysis)
1-Year Target
$12.36
(-10%)
2-Year Target
$11.12
(-19%)
3-Year Target
$10.01
(-27%)
3-Yr Target (if PE normalizes)
(PE: 16→24)
$14.64
(+7%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.6, Growth: 21.3%)
$31.38
(+129%)
Base:
(SPY PE: 16.1, Growth: 21.3%)
$24.51
(+79%)
Bear:
(PE: 13.7, Growth: 21.3%)
$20.83
(+52%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (25x PE), but valuation improves significantly next year (16x PE) as earnings recover.
Trailing PE: 25.17 | Current EPS (TTM): $0.58
Bull Case
$23.68
(+60%)
Analyst growth 47.4%, PE expands to 27.7
Base Case
$21.53
(+46%)
Market implied 47.4%, PE stable at 25.2
Bear Case
$9.93
(-33%)
Severe decline -20.0%, PE contracts to 21.4
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 16.1 to 23.5
Stabilization Target:
$20.08
(+46.3%)
PE Expansion Potential:
+46.3%
Share & Embed Analysis
Last updated: April 05, 2026 8:46 AM ET
Data refreshes hourly during market hours. Next update: 9:46 AM
Data refreshes hourly during market hours. Next update: 9:46 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is STVN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ISRG
Intuitive Surgical Inc |
BUY
33 analysts |
$607 | 58 HOLD |
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$94 | 61 BUY |
|
RGEN
Repligen Corporation |
STRONG BUY
19 analysts |
$186 | 60 BUY |
|
WST
West Pharmaceutical Serv… |
STRONG BUY
13 analysts |
$318 | 61 BUY |
|
AVTR
Avantor Inc |
HOLD
21 analysts |
$11 | 65 BUY |
